Biotech Values

[DewDiligence]

I noticed GSK breaking out Emerging Market sales this quarter I don't recall them doing that before (for any of their therapies).

You will see a lot more of this because emerging markets—branded generics in particular—are the future of the pharmaceutical industry. (Many analysts and investors curiously refuse to believe this, which is one reason Big Pharma stocks are so cheap.)

I have [Promacta] figures by territory but i-hub doesn't give a good way to post tables.

To post a table, use the [ pre ] and [ /pre ] delimiters (without the spaces); everything between these delimiters will be displayed in a fixed-width font so your columns and headers will line up.